Immuneering (IMRX) Enterprise Value (2021 - 2026)
Immuneering's Enterprise Value was $119.48 million in Q3 2026, up 138.3% from $50.13 million a year earlier but down 30.9% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Enterprise Value (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immuneering's Enterprise Value was -$359.95 million through Sep 30, 2026; for FY2025, it came in at $116.77 million, up 263.0% from FY2024.
- Enterprise Value shows a four-year compound annual growth rate of 13.3% (FY2021 to FY2025).
- In earlier years, Enterprise Value was $32.17 million in FY2024 (-75.2%), $129.48 million in FY2023 (+472.8%), $22.61 million in FY2022 (-68.1%) and $70.92 million in FY2021.
- Quarterly Enterprise Value has moved between -$21.77 million (Q2 2024) and $260.92 million (Q3 2022) over five years.
- Compared with a year earlier, Enterprise Value has increased for five straight quarters, with growth averaging 200.7% over the last seven quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2026 (growth of 878.2%); the worst was Q1 2024 (a decline of 91.3%).
- Per Business Quant data, IMRX's Enterprise Value in the three quarters before Q3 2026 was $172.94 million (Q2 2026), $184.22 million (Q1 2026) and $116.77 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 119.48 Mn |
| Jun 30, 2026 | 172.94 Mn |
| Mar 31, 2026 | 184.22 Mn |
| Dec 31, 2025 | 116.77 Mn |
| Sep 30, 2025 | 50.13 Mn |
| Jun 30, 2025 | 94.92 Mn |
| Mar 31, 2025 | 18.83 Mn |
| Dec 31, 2024 | 32.17 Mn |
| Sep 30, 2024 | 26.66 Mn |
| Jun 30, 2024 | -21.77 Mn |
| Mar 31, 2024 | 14.42 Mn |
| Dec 31, 2023 | 129.48 Mn |
| Sep 30, 2023 | 127.54 Mn |
| Jun 30, 2023 | 187.74 Mn |
| Mar 31, 2023 | 165.74 Mn |
| Dec 31, 2022 | 22.61 Mn |
| Sep 30, 2022 | 260.92 Mn |
| Jun 30, 2022 | 14.68 Mn |
| Mar 31, 2022 | 32.93 Mn |
| Dec 31, 2021 | 70.92 Mn |
API Access
Immuneering Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();